Certificate of Analysis
Third Party Tested
Molecular Profile
Compound
BPC-157
Batch #
N/A
Formula
C62H98N16O22
Mol Wt
1419.556 g/mol
CAS
137525-51-0
Compound
TB500
Batch #
N/A
Formula
C38H68N10O14
Mol Wt
885340-08-9
CAS
889 g/mol
latest
ISO 17025
8× Testing
99.64%
Purity
VariantBPC-157 / TB-500
COA ##13139
Labeled10mg
Validation KeyAXISBIOTECH
Tested05/12/26
Full QC Panel - 8× tested
✓
Purity (HPLC) - 99.64%
✓
Net Peptide Content - 10mg
✓
Identity (HPLC) - TB500
✓
Fentanyl Screen - Not Detected
✓
HPLC Conformity mean - >99%
✓
ISO/IEC 17025 Accredited
Storage Requirements
Stability Information
Lyophilized (powder)
−20°C long-term
2–8°C
Reconstituted
Recommended condition
Light protection
Store away from light
Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.
Peer-Reviewed Literature
Research & References
Research and reference material related to this compound.
01
Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review
02
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing
03
Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair
04
Multifunctionality and Possible Medical Application of the BPC 157 Peptide — Literature and Patent Review
05
Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development
Safety & Regulatory Compliance Warning
These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.
